Scolaris Content Display Scolaris Content Display

Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia

Esta versión no es la más reciente

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

The objective of this systematic review is to determine the optimal use of recombinant factor VIIa (rFVIIa) when used for the prophylactic or therapeutic management of haemorrhage in patients without haemophilia.